PT  - JOURNAL ARTICLE
AU  - Nicola L Harman
AU  - John P H Wilding
AU  - Dave Curry
AU  - James Harris
AU  - Jennifer Logue
AU  - R John Pemberton
AU  - Leigh Perreault
AU  - Gareth Thompson
AU  - Sean Tunis
AU  - Paula R Williamson
ED  - ,
TI  - Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
AID  - 10.1136/bmjdrc-2019-000700
DP  - 2019 Dec 01
TA  - BMJ Open Diabetes Research & Care
PG  - e000700
VI  - 7
IP  - 1
4099  - http://drc.bmj.com/content/7/1/e000700.short
4100  - http://drc.bmj.com/content/7/1/e000700.full
SO  - BMJ Open Diab Res Care2019 Dec 01; 7
AB  - Objectives Heterogeneity in outcomes measured across trials of glucose-lowering interventions for people with type 2 diabetes impacts on the ability to compare findings and may mean that the results have little importance to healthcare professionals and the patients that they care for. The SCORE-IT study (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes) has addressed this issue by establishing consensus on the most important outcomes for non-surgical interventions for hyperglycemia in type 2 diabetes.Research design and methods A comprehensive list of outcomes was developed from registered clinical trials, online patient resources, qualitative literature and long-term studies in the field. This list was then scored in a two-round online Delphi survey completed by healthcare professionals, people with type 2 diabetes, researchers in the field and healthcare policymakers. The results of this online Delphi were discussed and ratified at a face-to-face consensus meeting.Results 173 people completed both rounds of the online survey (116 people with type 2 diabetes, 37 healthcare professionals, 14 researchers and 6 policymakers), 20 of these attended the consensus meeting (13 people with type 2 diabetes and 7 healthcare professionals). Consensus was reached on 18 core outcomes across five domains, which include outcomes related to diabetes care, quality of life and long-term diabetes-related complications.Conclusions Implementation of the core outcome set in future trials will ensure that outcomes of importance to all stakeholders are measured and reported, enhancing the relevance of trial findings and facilitating the comparison of results across trials.